FFIV(FFIV)
FFIV
Q4 2026 EPS Estimate
$4.22
Oct 26, 2026 · Reports after close
Revenue Estimate
$884M
FY2026E EPS$17.33
FY2027E EPS$18.03
Analyst Sentiment
Wall St. Consensus
Buy19 analysts·Moderate coverage
64
Score
12 Buy (63%)6 Hold (32%)1 Sell (5%)
Rating Breakdown
Strong Buy
00%
Buy
1263%
Hold
632%
Sell
15%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$300.00
-28.6%
Consensus
$450.00
+7.1%
Bull
$475.00
+13.1%
12-Month Target Range19 analysts
$300.00$450.00$475.00
Current $420.12Consensus
Current Price
$420.12
Upside to Consensus
$29.88
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+7.38%
EPS+3.99%
FY2028
Rev+7.49%
EPS+11.67%
FY2029
Rev+3.23%
EPS+6.29%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $3.38B | $3.63B | $3.90B | $4.03B |
| Low | $3.34B | $3.46B | $3.75B | $3.94B |
| High | $3.42B | $3.78B | $4.06B | $4.12B |
| EBITDA Avg | $1.36B | $1.46B | $1.56B | $1.61B |
| Low | $1.34B | $1.39B | $1.50B | $1.58B |
| High | $1.37B | $1.52B | $1.63B | $1.65B |
| EBIT Avg | $1.30B | $1.39B | $1.50B | $1.55B |
| Low | $1.28B | $1.33B | $1.44B | $1.51B |
| High | $1.31B | $1.45B | $1.56B | $1.58B |
| Net Income Avg | $1.03B | $1.02B | $1.15B | $1.26B |
| Low | $1.01B | $1.02B | $1.02B | $1.22B |
| High | $1.06B | $1.08B | $1.34B | $1.29B |
| EPS Avg | $17.33 | $18.03 | $20.13 | $21.39 |
| Low | $17.14 | $17.32 | $17.41 | $20.74 |
| High | $18.08 | $18.43 | $22.85 | $22.02 |
| Analysts (Rev / EPS) | 9 / 8 | 9 / 8 | 9 / 2 | 6 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $884M | $873M | $876M | $918M | $949M | $953M | $924M | $975M |
| Low | $882M | $848M | $864M | $905M | $935M | $939M | $912M | $962M |
| High | $885M | $890M | $886M | $929M | $960M | $964M | $935M | $987M |
| EBITDA Avg | $354M | $350M | $351M | $368M | $380M | $382M | $370M | $391M |
| Low | $353M | $340M | $346M | $363M | $375M | $376M | $365M | $385M |
| High | $355M | $357M | $355M | $372M | $384M | $386M | $375M | $395M |
| EBIT Avg | $339M | $335M | $336M | $352M | $364M | $365M | $354M | $374M |
| Low | $338M | $325M | $331M | $347M | $359M | $360M | $350M | $369M |
| High | $340M | $341M | $340M | $356M | $368M | $369M | $359M | $378M |
| Net Income Avg | $245M | $252M | $242M | $264M | $281M | $282M | $258M | $285M |
| Low | $242M | $242M | $237M | $259M | $276M | $277M | $254M | $280M |
| High | $250M | $275M | $245M | $268M | $285M | $287M | $262M | $290M |
| EPS Avg | $4.26 | $4.36 | $4.19 | $4.58 | $4.88 | $4.90 | $4.48 | $4.95 |
| Low | $4.19 | $4.19 | $4.11 | $4.49 | $4.79 | $4.81 | $4.40 | $4.86 |
| High | $4.33 | $4.76 | $4.25 | $4.65 | $4.95 | $4.97 | $4.55 | $5.02 |
| Analysts (Rev / EPS) | 6 / 9 | 7 / 9 | 3 / 6 | 3 / 3 | 3 / 3 | 6 / 6 | 5 / 8 | 4 / 4 |